Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
United International Pharma (UIP) is a leading pharmaceutical manufacturer in Vietnam and a key subsidiary of the Philippines-based Unilab Group. Established in 1997, UIP was one of the first 100% foreign-invested pharmaceutical entities to build a manufacturing plant in Vietnam. The company operates a state-of-the-art facility in the Vietnam-Singapore Industrial Park (VSIP) that adheres to WHO-GMP, GLP, and GSP standards, and was the first in the country to achieve PICS/GMP certification. UIP specializes in the development, manufacturing, and marketing of a broad range of healthcare products, including over-the-counter (OTC) medicines, prescription drugs, and nutritional supplements. Its portfolio features iconic regional brands such as Decolgen, Alaxan, and Enervon, which address therapeutic areas like respiratory health, pain management, and clinical nutrition. The company plays a significant role in the Vietnamese healthcare landscape by providing high-quality, affordable medications to the domestic market and exporting to other Southeast Asian countries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on UIP Vietnam.